- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06133036
Fecal Continence Outcomes and Quality of Life After Excision of Sacrococcygeal Teratoma (Retrospective Study)
November 10, 2023 updated by: Mohamed Kamal Mohamed Sayed Khalil, Sohag University
Fecal Continence Outcomes and Quality of Life After Excision of Sacrococcygeal Teratma (Retrospective Study)
Sacrococcygeal teratoma is one of the most common tumors that occur in the neonatal period.
It presents either as a mass protruding from the sacrococcygeal region or as a pelviabdominal mass according to the type.
Surgical excision is the main treatment, most masses are benign, however some are malignant and require radiotherapy or chemotherapy.
Complications may occur due to pressure resulting from the tumor growth in the fetal period, or due to damage to important near tissues during surgical excision.
Postoperative complications may be urinary as neurogenic bladder, Lower gastrointestinal as constipation, soiling or incontinence.
In this work we study the outcomes of fecal continence through a questionnaire and its effect on the quality of life of the affected children.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mohamed K Khalil
- Phone Number: 01028900808
- Email: mohamedkamal@med.sohag.edu.eg
Study Locations
-
-
-
Sohag, Egypt, 82511
- Recruiting
- Sohag University hospitals
-
Contact:
- Mohamed K Khalil
- Phone Number: +201028900808
- Email: mohamedkamal@med.sohag.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients operated in Sohag university hospital after july 2010 for sacrococcygeal teratoma.
Description
Inclusion Criteria:
- all patients with sacrococcygeal teratoma operated after july 2010 and older than 3 years old.
Exclusion Criteria:
- Patients lost to follow up before 6 months after surgery.
- Patients with Currarino triad.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fecal continence
Time Frame: 6 months
|
Measured by Rintala continence score
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
November 1, 2023
Primary Completion (Estimated)
February 1, 2024
Study Completion (Estimated)
May 1, 2024
Study Registration Dates
First Submitted
November 10, 2023
First Submitted That Met QC Criteria
November 10, 2023
First Posted (Actual)
November 15, 2023
Study Record Updates
Last Update Posted (Actual)
November 15, 2023
Last Update Submitted That Met QC Criteria
November 10, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med-23-10-10MS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sacrococcygeal Teratoma
-
Assistance Publique - Hôpitaux de ParisCompletedSacrococcygeal TeratomaFrance
-
University Hospital, MontpellierCompletedVoiding Disorders | Neurogenic Bladder | Sacrococcygeal TeratomaFrance
-
Assistance Publique - Hôpitaux de ParisCompletedCURRARINO Syndrome | Sacrococcygeal Teratoma | Presacral MassFrance
-
Istanbul UniversityCompletedSacrococcygeal DisorderTurkey
-
Children's Healthcare of AtlantaTerminated
-
Federico II UniversityCompletedChronic Sacrococcygeal Pilonidal SinusItaly
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChoriocarcinoma | Embryonal Carcinoma | Mixed Germ Cell Tumor | Central Nervous System Nongerminomatous Germ Cell Tumor | Immature Teratoma | Malignant Teratoma | Pineal Region Germ Cell Tumor | Pineal Region Immature Teratoma | Pineal Region Yolk Sac Tumor | Suprasellar Germ Cell TumorUnited States, Australia, Canada, New Zealand
-
Faculdade de Medicina de CatanduvaCompleted
-
Ankara Mevki Military HospitalCompletedSacrococcygeal Pilonidal DiseaseTurkey
-
HJ23CompletedPilonidal Sinus | Pilonidal Disease | Sacrococcygeal Fistula | Pilonidal Disease of Natal CleftSpain